Sterling Round Scroll With Lapis Stone Cufflinks - Free Shipping

These beautiful round cufflinks have needlepoint detail and feature sterling silver and genuine lapis stone. The silver design overlapping the lapis makes for an ornate look. Approximately 3/4" in diameter, Genuine Lapis stone and Sterling Silver, Hand Carved Detail, One Piece, Fixed Backing, Made In Greece,

HANGZHOU, China (Reuters) - Alibaba Group Holding Ltd (BABA.N) will set up a dedicated chip subsidiary and aims to launch its first self-developed AI inference chip in the second half of 2019 that could be used for autonomous driving, smart cities and logistics. The Chinese firm said at an event in Hangzhou on Wednesday that the new subsidiary would make customised AI chips and embedded processors to support the firm’s push into fast-growing cloud and internet of things (IoT) businesses. Alibaba’s aggressive drive to develop its own semiconductors comes as China’s government looks to raise the quality of home-made chips to help propel high-tech domestic industries from cutting-edge transport to AI healthcare systems.

HUANGZHOU, China/FRANKFURT (Reuters) - SAP SE (SAPG.DE), sterling round scroll with lapis stone cufflinks the German business software company, said on Wednesday it was teaming up with Alibaba (BABA.N) to offer its flagship products on the Chinese company’s cloud infrastructure, SAP Chief Executive Bill McDermott said the group would offer its S/4HANA Cloud and SAP Cloud Platform products via Alibaba, enabling companies in China run their business processes using an Infrastructure as a Service (IaaS) model, SAP, Europe’s most valuable technology company, also cooperates with U.S, cloud providers as it encourages clients to make a transition away from running its software on on-site servers to remote data centres..

WUXI, China/LONDON (Reuters) - With smart cancer diagnostics, one-stop-shop diabetes kits and AI systems to improve ambulance pick-ups for patients with chest pain, AstraZeneca (AZN.L) aims to move from simply supplying drugs to become a broad healthcare provider in China. Tech tie-ups with the likes of Alibaba (BABA.N) and Tencent (0700.HK) will not directly lift the British group’s drug sales, since they are not specific for any one company’s products and in many cases will be low-cost or free.

But it will expand the overall market and represents a soft power play that dovetails neatly with Beijing’s support for Internet-based healthcare systems to alleviate a lack of doctors, overcrowding and poor grassroots healthcare, “Down the line we benefit, our products benefit, because we have better relationships with doctors and hospital managers and also because we diagnose more patients and they get better treated,” Chief Executive Pascal Soriot told Reuters, Surrounded by the latest gizmos at the World Internet of sterling round scroll with lapis stone cufflinks Things Exposition in Wuxi, eastern China, Soriot says he wants to use the power of artificial intelligence, robots and apps to help transform diagnosis and disease management..

AstraZeneca has been on a tear in China, more than doubling its sales since 2012, helped by regulatory reforms to fast-track new drugs, and today generates 18 percent of revenue in the country — a far higher proportion than rivals. Yet Soriot is anxious to do more to keep doctors and government officials on-side in the world’s second-biggest drugs market, as soaring demand strains the state insurance system and squeezes medicine prices. The company’s underlying conviction is that it has the right medicines across chronic diseases like cancer, diabetes and respiratory disorders to win in China.

Soriot believes that can keep AstraZeneca growing in a pivotal market in the coming years, even though annual growth is likely to slow to nearer 15 percent from the breakneck 33 percent seen in the first half of 2018, The company has moved quickly to exploit China’s sterling round scroll with lapis stone cufflinks new-found willingness to use innovative Western drugs, Last year it won a record-fast approval for lung cancer pill Tagrisso, which is designed for patients with a genetic mutation that is particularly common in China, It hopes to get a green light before the end of 2018 — well before U.S, approval — for a new anemia drug called roxadustat being developed with FibroGen (FGEN.O)..

China-first approvals for drugs like roxadustat and Elunate, a colorectal cancer treatment from Eli Lilly (LLY.N) and Hutchison China MediTech (HCM.L), mark a reversal of the historical pattern of Chinese patients getting new drugs years after their launch in the West. There is, however, a trade-off. Multinationals that relied in the past on selling older drugs at premium prices in China are seeing prices slashed. AstraZeneca took a 50 percent haircut last year on the price of Iressa, its predecessor to Tagrisso.

“The government wants to give access to better medicines to more people,” said Soriot, who admitted that pressure on prices had come sooner than he expected, “To some extent the economy is growing so there is more money to do that, but there is not enough money ., They have to make room in the budget for innovation.”, With 1.4 billion sterling round scroll with lapis stone cufflinks people, around 18 percent of the world’s population, China has more cases of cancer and diabetes than any other nation, fueled by fast food, smoking and pollution, global health data show..

Recent Posts